September 17, 2022
mayank
Motilal Oswal S&P BSE Healthcare ETF
NAV Growth : Rs 22.7118
Suitable For Which Investors ?
This is a fund that invests mainly in shares of pharmaceutical and healthcare companies.
We believe that investors should avoid funds that have a narrowly defined investment mandate such as this one. Instead, they should invest in flexi-cap funds which provide complete freedom to the fund management team to invest in companies from which it expects maximum gains.
But if you do invest, you must do so only through the SIP route.
Fund’s Investment Strategy :
The scheme seeks to provide returns that, before expenses, correspond to the total returns of the securities as represented by the underlying index, subject to tracking error.
Fund Manager :
1) Swapnil P Mayekar
Education : Mr. Mayekar is an M.Com from Mumbai University and also holds an Advanced Diploma in Business Administration from Welingkar, Mumbai.
Experience : Prior to joining Motilal Oswal AMC he worked with Business Standard Limited from Aug 2005 to Feb 2010.
2) Abhiroop Mukherjee
Education : Mr. Abhiroop Mukherjee holds B.Com from Calcutta University & PGPBF (Finance) from National Institute of Bank Management.
Experience : Prior to joining Motilal Oswal AMC, he has worked with PNB Gilts Ltd. Mumbai.
Investment Details
| Min. Investment (Rs) : | 500 |
| Min. Addl Investment (Rs) : | — |
| Min. SIP Investment (Rs) : | — |
| Min. Withdrawal (Rs) : | — |
| Min. No of Cheques : | — |
| Min. Balance (Rs) : | — |
| Lock-in Period : | NA |
| Exit Load : | 0 |
Basic Details
| Fund House : | Motilal Oswal Mutual Fund |
| Launch Date : | 29-Jul-22 |
| Return Since Launch : | -2.34% |
| Benchmark : | S&P BSE Healthcare TRI |
| Riskometer : | Very High |
| Type : | Open-ended |
| Assets : | Rs 6 Cr |
| (As on 31-Aug-2022) | |
| Expense Ratio : | 0.20% |
| (As on 31-Jul-2022) | |
| Risk Grade : | — |
| Return Grade : | — |
| Turnover : | — |
Motilal Oswal S&P BSE Healthcare ETF Trailing Returns (%)
| Fund name | YTD | 1D | 1M | 3M | 6M | 1Y | 3Y | 5Y | 7Y | 10Y |
| Motilal Oswal S&P BSE Helthcr ETF | — | -1.43 | -2.4 | — | — | — | — | — | — | — |
| S&P BSE Healthcare TRI | — | -1.43 | -2.35 | — | — | — | — | — | — | — |
| Equity: Sectoral-Pharma | — | -1.35 | -2.82 | — | — | — | — | — | — | — |
| Rank within category | — | 12 | 6 | — | — | — | — | — | — | — |
| Number of funds in category | 14 | 15 | 15 | 14 | 14 | 12 | 9 | 4 | 3 | 3 |
Motilal Oswal S&P BSE Healthcare ETF Peer Comparison
| Fund name | Rating | 1 Year Returns | 3 Year Returns | 5 Year Returns | Expense Ratio (%) | Net Assets (Rs Cr) | Return Since Launch (%) | Exit Load (Days) | Fund Age | Turnover (%) |
| Motilal Oswal S&P BSE Helthcr ETF | Unrated | — | — | — | 0.20 | 6 | -2.34 | — | 0yrs 1mo | — |
| Nippon Ind Pharma Reg | Unrated | -14.07 | 23.85 | 16.14 | 1.98 | 4,588 | 19.8 | 1.00 (30) | 18yrs 3mo | 28.00 |
| ICICI Pru Pharma Hlthcr & Diagn Reg | Unrated | -13.20 | 24.48 | — | 2.25 | 2,465 | 16.21 | 1.00 (15) | 4yrs 2mo | 48.00 |
| Mirae Asset Helthcr Reg | Unrated | -12.44 | 26.78 | — | 2.10 | 1,723 | 19.47 | 1.00 (365) | 4yrs 2mo | 29.00 |
| SBI Helthcr Opp Reg | Unrated | -9.78 | 24.00 | 11.74 | 2.18 | 1,675 | 15.43 | 0.50 (15) | 23yrs 2mo | 27.00 |
Portfolio Analysis
| No. of Stocks : | 97 |
| Top 10 Stocks % : | 62.84 |
| Top 5 Stocks % : | 48.28 |
| Top 3 Sectors % : | 99.57 |
| Portfolio P/B Ratio : | 4.13 |
| Portfolio P/E Ratio : | 35.85 |
Portfolio Breakup
| Fund | Category | |
| Average Mkt Cap (Rs Cr) | 42,856 | 55,278 |
| Giant (%) | 16.10 | 19.26 |
| Large (%) | 34.93 | 36.52 |
| Mid (%) | 38.42 | 36.17 |
| Small (%) | 10.28 | 7.94 |
| Tiny (%) | 0.27 | 0.55 |
Motilal Oswal S&P BSE Healthcare ETF by Chanakya :
Do not invest in this, or any other pharma sector fund, if you need to redeem your investment in less than seven years.
Apply Online :
Stock Research Reports :
https://www.analysislibrary.com/
NFO Guidance :
https://sahifund.com/category/nfos/
Chanakya’s Mutual Fund Guidance on Youtube
https://www.youtube.com/c/ChanakyaNiPothi
Join Chanakya’s Telegram Channel @
https://t.me/chanakyanipothi